Business Description
Melodiol Global Health Ltd
ISIN : AU0000282840
Compare
Compare
Traded in other countries / regions
ME1.Australia1X80.GermanyCOPHF.USA IPO Date
2016-10-20Description
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: USA-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | -0.21 | |||||
| Debt-to-Equity | -2.38 | |||||
| Debt-to-EBITDA | -0.39 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -17.04 | |||||
| Beneish M-Score | -11.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.9 | |||||
| 3-Year EBITDA Growth Rate | 45.9 | |||||
| 3-Year EPS without NRI Growth Rate | 48.3 | |||||
| 3-Year FCF Growth Rate | 51.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 25.9 | |||||
| 14-Day RSI | 46.21 | |||||
| 6-1 Month Momentum % | -99.74 | |||||
| 12-1 Month Momentum % | -99.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.24 | |||||
| Quick Ratio | 0.18 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 69.53 | |||||
| Days Sales Outstanding | 58.35 | |||||
| Days Payable | 186.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -73.7 | |||||
| Shareholder Yield % | -714.25 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.34 | |||||
| Operating Margin % | -88.16 | |||||
| Net Margin % | -277.18 | |||||
| FCF Margin % | -44.68 | |||||
| ROE % | -576.69 | |||||
| ROA % | -175.15 | |||||
| ROIC % | -55.86 | |||||
| ROC (Joel Greenblatt) % | -252.53 | |||||
| ROCE % | -280.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.39 | |||||
| EV-to-EBITDA | -0.41 | |||||
| EV-to-Revenue | 0.53 | |||||
| EV-to-FCF | -1.19 | |||||
| Earnings Yield (Greenblatt) % | -256.41 | |||||
| FCF Yield % | -750.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Melodiol Global Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 18.921 | ||
| EPS (TTM) (A$) | -11.28 | ||
| Beta | 0 | ||
| Volatility % | 106.33 | ||
| 14-Day RSI | 46.21 | ||
| 14-Day ATR (A$) | 0.000541 | ||
| 20-Day SMA (A$) | 0.001 | ||
| 12-1 Month Momentum % | -99.96 | ||
| 52-Week Range (A$) | 0.001 - 14399.999712 | ||
| Shares Outstanding (Mil) | 1,125.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Melodiol Global Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Melodiol Global Health Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Melodiol Global Health Ltd Frequently Asked Questions
What is Melodiol Global Health Ltd(ASX:ME1)'s stock price today?
The current price of ASX:ME1 is A$0.00. The 52 week high of ASX:ME1 is A$14400.00 and 52 week low is A$0.00.
When is next earnings date of Melodiol Global Health Ltd(ASX:ME1)?
The next earnings date of Melodiol Global Health Ltd(ASX:ME1) is .
Does Melodiol Global Health Ltd(ASX:ME1) pay dividends? If so, how much?
Melodiol Global Health Ltd(ASX:ME1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers